ReviewCancer communications (London, England)2019

Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.

Chang Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.